Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$46.00 | Gbdgw | Hydhfprxf |
Narrow-Moat Bio-Techne Meets High Expectations to End Fiscal 2021; Maintain $230 FVE
Narrow-moat Bio-Techne had a strong end to the fiscal year and met our high expectations. We are maintaining our $230 fair value estimate after incorporating our expectation for a weighted-average U.S. corporate tax rate of 26%.